Digital healthcare is a growing topic within mental health given most existing treatments for mental health have been pharmacological.
Developing a go-to-market and monetization strategy is often product- and market- specific so requires in-depth knowledge of the healthcare landscape.
Our client, a start-up company offering a portfolio of prescription and non-prescription digital therapeutics in mental health, had started to experiment with several to-to-market routes and was now looking for external support to develop the optimal go-to-market and monetization strategy.
Our team assessed the current approach, determined the market access and monetization potential, and defined a strategy.
Firstly, we validated the current go-to-market approach by utilizing our own Simon-Kucher assessment framework and extensive industry experience.
Secondly, we assessed the market access and monetization potential via external expert discussions and client-internal experience.
Thirdly, we defined a g-to-market and monetization strategy for our client’s product portfolio that was both product- and market- specific.
Our work optimized the product- and market-specific go-to-market and monetization strategy for our client’s product portfolio in the US, UK, and DE.
We helped our client by providing actionable recommendations on the optimal access pathway(s), price levels, and models as well as additional success factors for maximization of the opportunity.
お問い合わせ
サイモン・クチャーのエキスパートがいつでもご相談に応じます。お気軽にお問い合わせください。